Industry Symposium:
The many faces of Janus Kinase inhibitors in rheumatology
Supported by Pfizer
| 11:00-12:00 | Industry Symposium: The many faces of Janus Kinase inhibitors in rheumatology Supported by Pfizer |
| Chairperson | Wen-Chan Tsai, Taiwan |
| 11:00 | Mechanisms of action and rational for the use of JAK inhibitors in RA and PsA Tsutomu Takeuchi, Japan |
| 11:20 | How to best use the JAK inhibitors: Lessons learned from the clinical trials and real life use Boulos Haraoui, Canada |
| 11:40 | Q&A/Discussion |